Royalty Pharma Plc (RPRX)
45.19
+0.39
(+0.87%)
USD |
NASDAQ |
Feb 13, 16:00
45.20
+0.01
(+0.02%)
Pre-Market: 20:00
Royalty Pharma Cash from Investing (Quarterly) : -852.80M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Denali Therapeutics, Inc. | 57.83M |
| PTC Therapeutics, Inc. | -289.62M |
| Veru, Inc. | 0.00 |
| Incyte Corp. | -37.42M |
| Vertex Pharmaceuticals, Inc. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 832.14M |
| Cash from Financing (Quarterly) | -299.60M |
| Free Cash Flow | 897.24M |
| Free Cash Flow Per Share (Quarterly) | 0.2297 |
| Free Cash Flow to Equity (Quarterly) | 94.08M |
| Free Cash Flow to Firm (Quarterly) | 192.63M |
| Free Cash Flow Yield | 3.73% |